Ad is loading...
INZY
Price
$3.13
Change
-$0.31 (-9.04%)
Updated
Nov 15 closing price
123 days until earnings call
KALV
Price
$9.49
Change
-$0.31 (-3.16%)
Updated
Nov 15 closing price
18 days until earnings call
Ad is loading...

INZY vs KALV

Header iconINZY vs KALV Comparison
Open Charts INZY vs KALVBanner chart's image
Inozyme Pharma
Price$3.13
Change-$0.31 (-9.04%)
Volume$474.4K
CapitalizationN/A
KalVista Pharmaceuticals
Price$9.49
Change-$0.31 (-3.16%)
Volume$816.28K
CapitalizationN/A
INZY vs KALV Comparison Chart
Loading...
INZY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
KALV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
INZY vs. KALV commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INZY is a Sell and KALV is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (INZY: $3.13 vs. KALV: $9.49)
Brand notoriety: INZY and KALV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INZY: 185% vs. KALV: 198%
Market capitalization -- INZY: $200.75M vs. KALV: $467.05M
INZY [@Biotechnology] is valued at $200.75M. KALV’s [@Biotechnology] market capitalization is $467.05M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INZY’s FA Score shows that 0 FA rating(s) are green whileKALV’s FA Score has 0 green FA rating(s).

  • INZY’s FA Score: 0 green, 5 red.
  • KALV’s FA Score: 0 green, 5 red.
According to our system of comparison, KALV is a better buy in the long-term than INZY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INZY’s TA Score shows that 4 TA indicator(s) are bullish while KALV’s TA Score has 4 bullish TA indicator(s).

  • INZY’s TA Score: 4 bullish, 7 bearish.
  • KALV’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, KALV is a better buy in the short-term than INZY.

Price Growth

INZY (@Biotechnology) experienced а -22.26% price change this week, while KALV (@Biotechnology) price change was -16.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

INZY is expected to report earnings on Mar 20, 2025.

KALV is expected to report earnings on Mar 12, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KALV($467M) has a higher market cap than INZY($201M). KALV YTD gains are higher at: -22.531 vs. INZY (-26.643). INZY has higher annual earnings (EBITDA): -82.82M vs. KALV (-131.18M). KALV has more cash in the bank: 210M vs. INZY (145M). KALV has less debt than INZY: KALV (7.32M) vs INZY (46.7M). INZY (0) and KALV (0) have equivalent revenues.
INZYKALVINZY / KALV
Capitalization201M467M43%
EBITDA-82.82M-131.18M63%
Gain YTD-26.643-22.531118%
P/E RatioN/AN/A-
Revenue00-
Total Cash145M210M69%
Total Debt46.7M7.32M638%
FUNDAMENTALS RATINGS
KALV: Fundamental Ratings
KALV
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
43

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INZYKALV
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 14 days ago
86%
Bullish Trend 14 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
84%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
INZY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
KALV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VCSOX24.50-0.16
-0.65%
VALIC Company I Intl Sclly Rspnb
SGPSX87.31-0.94
-1.07%
ProFunds Small Cap Growth Svc
ODIIX135.14-2.00
-1.46%
Invesco Discovery R6
GSAOX17.00-0.31
-1.79%
Goldman Sachs Small Cap Gr Insghts A
ETIHX33.97-1.69
-4.74%
Eventide Healthcare & Life Sciences I

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with BEAM. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
-8.89%
BEAM - INZY
58%
Loosely correlated
-8.59%
FATE - INZY
53%
Loosely correlated
-2.88%
PGEN - INZY
50%
Loosely correlated
-7.11%
DNLI - INZY
50%
Loosely correlated
-11.95%
NTLA - INZY
50%
Loosely correlated
-7.61%
More

KALV and

Correlation & Price change

A.I.dvisor indicates that over the last year, KALV has been loosely correlated with FATE. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if KALV jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KALV
1D Price
Change %
KALV100%
-3.16%
FATE - KALV
45%
Loosely correlated
-2.88%
INZY - KALV
44%
Loosely correlated
-8.89%
PLRX - KALV
42%
Loosely correlated
-3.27%
ALLO - KALV
41%
Loosely correlated
-7.72%
IDYA - KALV
41%
Loosely correlated
-9.60%
More